ERBB2 and breast carcinoma: Our results do not preclude that proteins might be useful in predicting certain types of breast cancer, either defined by its aggressiveness (i.e., grade and lymph node involvement) or by cell surface markers (such as oestrogen receptor or human epidermal growth factor receptor 2 (HER2) status) [39].